These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36864399)

  • 21. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition.
    Xiong C; Zhu Y; Xue M; Jiang Y; Zhong Y; Jiang L; Shi M; Chen H
    Aging (Albany NY); 2021 Jan; 13(3):3386-3404. PubMed ID: 33428605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-resident CXCR4
    Liao Z; Ye L; Li T; Jin X; Lin X; Fei Q; Zhang H; Shi S; Yu X; Jin K; Wu W
    Int J Cancer; 2023 Jun; 152(11):2396-2409. PubMed ID: 36757203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
    Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
    Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
    Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
    Cell Res; 2019 Sep; 29(9):725-738. PubMed ID: 31273297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation.
    Zhang J; Song J; Tang S; Zhao Y; Wang L; Luo Y; Tang J; Ji Y; Wang X; Li T; Zhang H; Shao W; Sheng J; Liang T; Bai X
    Cell Rep; 2023 Jun; 42(6):112620. PubMed ID: 37285267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC.
    Zhu S; Cheng Q; Zou M; Li C; Tang Y; Xia L; Jiang Y; Gong Z; Tang Z; Tang Y; Luo H; Peng N; Wang X; Dong X
    J Cell Mol Med; 2024 Apr; 28(7):e18266. PubMed ID: 38501838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway.
    Sun L; Zhang X; Song Q; Liu L; Forbes E; Tian W; Zhang Z; Kang Y; Wang H; Fleming JB; Pasche BC; Zhang W
    Cancer Lett; 2021 Mar; 500():132-146. PubMed ID: 33309859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of single nuclear chromatin accessibility reveals unique myeloid populations in human pancreatic ductal adenocarcinoma.
    Pratt HG; Ma L; Dziadowicz SA; Ott S; Whalley T; Szomolay B; Eubank TD; Hu G; Boone BA
    Clin Transl Med; 2024 Mar; 14(3):e1595. PubMed ID: 38426634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pancreatic cancer organoid incorporating macrophages reveals the correlation between the diversity of tumor-associated macrophages and cancer cell survival.
    Tabe S; Takeuchi K; Aoshima K; Okumura A; Yamamoto Y; Yanagisawa K; Eto R; Matsuo M; Ueno Y; Konishi T; Furukawa Y; Yamaguchi K; Morinaga S; Miyagi Y; Ohtsuka M; Tanimizu N; Taniguchi H
    Biomaterials; 2025 Mar; 314():122838. PubMed ID: 39348736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma.
    Ye H; Zhou Q; Zheng S; Li G; Lin Q; Wei L; Fu Z; Zhang B; Liu Y; Li Z; Chen R
    Cell Death Dis; 2018 May; 9(5):453. PubMed ID: 29670110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.
    Werba G; Weissinger D; Kawaler EA; Zhao E; Kalfakakou D; Dhara S; Wang L; Lim HB; Oh G; Jing X; Beri N; Khanna L; Gonda T; Oberstein P; Hajdu C; Loomis C; Heguy A; Sherman MH; Lund AW; Welling TH; Dolgalev I; Tsirigos A; Simeone DM
    Nat Commun; 2023 Feb; 14(1):797. PubMed ID: 36781852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
    Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
    Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway.
    Ma X; Wu D; Zhou S; Wan F; Liu H; Xu X; Xu X; Zhao Y; Tang M
    Oncol Rep; 2016 Jan; 35(1):189-96. PubMed ID: 26531138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer.
    Li TJ; Jin KZ; Li H; Ye LY; Li PC; Jiang B; Lin X; Liao ZY; Zhang HR; Shi SM; Lin MX; Fei QL; Xiao ZW; Xu HX; Liu L; Yu XJ; Wu WD
    Cancer Lett; 2022 Apr; 530():142-155. PubMed ID: 35077803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer.
    Chen K; Wang Y; Hou Y; Wang Q; Long D; Liu X; Tian X; Yang Y
    Cancer Lett; 2022 Oct; 545():215834. PubMed ID: 35917973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma.
    Patterson MT; Burrack AL; Xu Y; Hickok GH; Schmiechen ZC; Becker S; Cruz-Hinojoza E; Schrank PR; Kennedy AE; Firulyova MM; Miller EA; Zaitsev K; Williams JW; Stromnes IM
    Cell Rep; 2023 Jul; 42(7):112732. PubMed ID: 37402168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
    Arima K; Komohara Y; Bu L; Tsukamoto M; Itoyama R; Miyake K; Uchihara T; Ogata Y; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Yamashita YI; Baba H; Ishimoto T
    Cancer Sci; 2018 Feb; 109(2):462-470. PubMed ID: 29224225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.